2 Dec 2019
Taste-related protein provides target for drugs to treat neurological disorders
GRAND RAPIDS, Mich. (Dec. 2, 2019) — Understanding how the brain processes sweet, bitter and umami tastes may one day help researchers...Read More
6 Nov 2019
New technique lays foundation for regenerative cardiac therapies
GRAND RAPIDS, Mich. (Nov. 6, 2019) — Scientists have devised a technique to sort out which heart cells can replicate and which...Read More
29 Oct 2019
Van Andel Institute Graduate School’s Dr. Steven Triezenberg to lead the Cancer Biology Training Consortium
GRAND RAPIDS, Mich. (Oct. 29, 2019) — Van Andel Institute Graduate School Dean Steven J. Triezenberg, Ph.D., has been elected as president...Read More
21 Oct 2019
Can a diabetes drug slow or stop a devastating neurodegenerative disease?
A new clinical trial gives hope to people with multiple system atrophy Philip Fortier is on a mission: to find a cure...Read More
21 Oct 2019
Researchers begin trial of drug to slow progression of neurodegenerative condition multiple system atrophy
NOTE: This release was originally published by University College London, here. Researchers at UCL Queen Square Institute of Neurology (IoN) and the...Read More
18 Oct 2019
How Van Andel Institute supports clinical trials through collaboration and connection
Institute serves as a connector that fosters discovery of potential new treatments
28 Aug 2019
Can suicide risk be detected in the blood?
Five-year, $3.6 million federal grant to fuel search for biomarker-based methods to evaluate suicide risk GRAND RAPIDS, Mich. (Aug. 28, 2019) —...Read More
23 Aug 2019
Scientists and people with Parkinson’s join forces to explore genetic risks in Parkinson’s disease
More than 200 years ago, British surgeon Dr. James Parkinson penned an essay about “the shaking palsy,” a mysterious disorder that would...Read More
